entity

NO

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NO: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

12Connections
30Hypotheses
0Analyses
7Outgoing
5Incoming
15Experiments
0Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

CERNUNNOS Gene

gene · 2570 words

LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Disease

clinical · 2408 words

ANO9 — Anoctamin 9

gene · 2171 words

NOTCH2 — Notch Receptor 2

gene · 2167 words

NOB1 Protein — NinOne Binding Protein 1

protein · 2134 words

Outgoing (7)

TargetRelationTypeStr
Neuroprotectionmediatesprocess0.90
Learning And Memoryinvolved_inprocess0.90
NEURONprotects_againstcell_type0.80
Neuronsmodulatescell_type0.75
Astrocytesmodulatescell_type0.75

Incoming (5)

SourceRelationTypeStr
19371326combines withpaper0.90
MICROGLIAL CELLproducescell_type0.80
DHTinhibitscompound0.80
MICROGLIAactivatescell_type0.64
PLGFactivatesprotein0.56

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.824 neurodegeneration What are the mechanisms by which gut mic
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S 0.822 neurodegeneration What are the mechanisms by which gut mic
Kinetic Modeling Predicts Threshold-Dependent Efficacy—Early 0.815 protein-folding Can chaperone enhancement approaches ove
p16^INK4a-CCF Axis as Senolytic Timing Biomarker 0.805 molecular-biology What is the optimal therapeutic window t
Targeted Butyrate Supplementation for Microglial Phenotype M 0.805 neurodegeneration What are the mechanisms by which gut mic
ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 0.802 lipidomics Lipid metabolism dysregulation in Alzhei
NLRP3 inflammasome amplification across AD and PD proteinopa 0.800 multi Cross-disease neurodegeneration mechanis
Senescent Microglia Resolution via Maresins-Senolytics Combi 0.791 neurodegeneration Neuroinflammation resolution mechanisms
Therapeutic Window Exists Because Amplified Signals (Not Bas 0.780 neurodegeneration Do pathogenic LRRK2 mutations amplify vo
CX3CR1-TREM2 Integration for Synapse Pruning Normalization 0.776 neurodegeneration TREM2 agonism vs antagonism in DAM micro
H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from E 0.770 neurodegeneration Investigate mechanisms of epigenetic rep
Selective LXRβ agonists restore ABCA1/ABCG1 expression and A 0.763 neuroscience APOE4-driven lipid metabolism dysregulat
TDP-43 Proteinopathy as a Cross-Disease Pathological Substra 0.760 neurodegeneration Cross-disease neurodegeneration mechanis
Peripheral Monocyte/Macrophage Infiltration Mimicking Microg 0.743 neuroinflammation What causes IBA1 low/negative microglia
APOE4-Selective Lipid Nanoemulsion Therapy 0.742 neurodegeneration Mechanistic role of APOE in neurodegener
Tau missorting transitions into an autonomous tau-seeding st 0.740 neurodegeneration Does tau dendritic missorting persist in
SNCA Oligomer Binding to LAMP2A Cytosolic Tail Prevents Tors 0.733 neurodegeneration -
Adenosine-Astrocyte Metabolic Reset 0.730 neurodegeneration Sleep disruption as cause and consequenc
TFAM overexpression creates mitochondrial donor-recipient gr 0.725 neurodegeneration Mitochondrial transfer between astrocyte
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In 0.720 neurodegeneration What molecular mechanisms drive microgli
Noradrenergic-Tau Propagation Blockade 0.711 neurodegeneration Sleep disruption as cause and consequenc
H4: Senomorphic Compounds Preserve Astrocyte Function While 0.710 neurodegeneration Do APOE4-driven senescent astrocytes cau
LRRK2 kinase inhibition to normalize lysosomal trafficking i 0.710 neurodegeneration Test
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In 0.709 neurodegeneration Perivascular spaces and glymphatic clear
CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of A 0.705 - What blood-brain barrier permeability ch
Spatiotemporal coupling between TRPML1-mediated lysosomal ca 0.705 neurodegeneration What determines the specificity of calci
AAV-Mediated APOE2/APOE3 Gene Delivery to Convert APOE Genot 0.700 neurodegeneration APOE4 targeting in neurodegeneration
Pericyte-targeted senolysis or senomorphic therapy will bene 0.700 neurodegeneration Does pericyte senescence drive BBB break
Mechanosensitive Ion Channel Reprogramming 0.700 neurodegeneration Astrocyte reactivity subtypes in neurode
Closed-loop transcranial focused ultrasound with gamma entra 0.000 alzheimers Circuit-level neural dynamics in neurode

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (15)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Mobile App-Based Intervention for BPSD in Community-Dwelling Dementia clinical dementia with behavioral and p 0.950 0.00 human patients proposed N/A
GPR109A receptor validation using knockout macrophages exploratory Mycoplasma pneumoniae pneumoni 0.920 0.00 GPR109A knockout mouse macroph proposed N/A
Periodontitis-induced colonic inflammation in mice validation Periodontitis and intestinal i 0.900 0.00 C57BL/6J mice proposed N/A
Fecal microbiota transplantation from periodontitis donors validation Periodontitis-associated gut d 0.900 0.00 Germ-free mice with fecal micr proposed N/A
GPR109A functional modulation with pharmacological agents validation Periodontitis with intestinal 0.880 0.00 C57BL/6J mice with ligature-in proposed N/A
Probiotic CBM588 supplementation rescue experiment validation Periodontitis-associated intes 0.850 0.00 C57BL/6J mice with periodontit proposed N/A
Proposed experiment from debate on Senolytics targeting p16/p21+ senes falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%? clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000
cGAS-STING Pathway Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the validation Alzheimer's Disease 0.400 0.50 human proposed $2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis validation Neuroinflammation 0.400 0.50 human proposed $2,960,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship validation Alzheimer's Disease 0.400 0.50 human proposed $3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the S [PMID:37738560] Justice JN, Leng XI, LeBrasseur NK, Tchk J Gerontol A Biol Sci Med Sci 2024 1
Sex differences in autophagy-mediated diseases: toward precision medicine. [PMID:32264724] Shang D, Wang L, Klionsky DJ, Cheng H, Z Autophagy 2021 1
Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populatio [PMID:33144684] He D, Wang D, Lu P, Yang N, Xue Z, Zhu X Oncogene 2021 1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] ["Han X", "Sun S", "Sun Y", "Song Q", "Z Autophagy 2020 1
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells [PMID:26657143] Chang J, Wang Y, Shao L, Laberge RM, Dem Nat Med 2016 1
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. [PMID:25754370] Zhu Y, Tchkonia T, Pirtskhalava T, Gower Aging Cell 2015 1
GPR109a-AMPK axis mediates the Attenuation of uric acid-induced M1 macrophage po [PMID:41882026] Du M, He Y, Zhu Y, Chen W, Chen X, Yang Scientific reports 2026 0
Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppres [PMID:41638192] Ding N, Wu H, Hua Y, Hua R, Li B, Xie Y, Cell metabolism 2026 0
Senolytic elimination of therapy-induced senescent cells by ABT-263 improves che [PMID:41423036] Zhang D, Zhu J, Zou R, Zhang H, Yu BP, L Biochemical pharmacology 2026 0
Therapeutic strategies for hypertension: exploring the role of microbiota-derive [PMID:40637840] Tortelote GG Pediatr Nephrol 2026 0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] Li X, Tang X, Zeng J, Duan L, Hou Z et a Cell 2026 0
UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413] Yang H, Li Y, Su J, Zhang H, Zhu W et al Front Immunol 2026 0
Comprehensive assessment of the genomic stability of human induced pluripotent s [PMID:41877289] Zhang K, Na T, Jia C, Yuan X, Guo M, Yan Stem cell research & therapy 2026 0
Characterization of the Direct and Indirect Inhibition of Apoptosis by Full-Leng [PMID:41589352] Elsner C, Epasto LM, Cieren A, Gendreizi Chembiochem : a European journ 2026 0
Xin-Jia-Tong-Xie-Yao-Fang restores the intestinal barrier to alleviate irritable [PMID:41655800] Zhu J, Yang L, Fang Z, Chen J, Fu R, Liu Microbial pathogenesis 2026 0
Exploring the key molecular mechanisms and immune microenvironment of oxidative [PMID:41591671] Cai Z, Li J, Li T, Peng Q Discover oncology 2026 0
Cranberry extract-supplemented microbiota effluents enhance intestinal barrier i [PMID:41680408] Cattero V, Mayer T, Veilleux A, Roussel Scientific reports 2026 0
Qingfei Tongluo Jiedu Formula Regulates M2 Macrophage Polarization via the Butyr [PMID:41754753] Liu Z, Fan Q, Sun R, Jiang Y Pharmaceuticals (Basel, Switze 2026 0
Periodontitis promotes intestinal inflammation through gut microbiota-mediated s [PMID:41816355] Wang X, Xu Z, Yao Y, Jia H, Du M, Wang S Frontiers in cellular and infe 2026 0
Hydroxycarboxylic acid receptor 2 (GPR109A) and retinopathies: pathways and pros [PMID:41889514] Lester J, Amamoo R, Thounaojam MC, Marti Frontiers in medicine 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning NO in their description or question text

ω-3 Docosahexaenoic Acid (DHA) Epoxide Generation via CYP2J2 to Protect Synaptic

Score: 0.802 · lipidomics · 2026-04-25

The hypothesis proposes that ω-3 docosahexaenoic acid (DHA) is metabolized by CYP2J2 to generate protective epoxides tha

NLRP3 inflammasome amplification across AD and PD proteinopathy

Score: 0.800 · multi · 2026-04-28

Shared mechanism across AD, PD: Misfolded protein stress activates microglial NLRP3; IL-1 beta and inflammasome signalin

Senescent Microglia Resolution via Maresins-Senolytics Combination

Score: 0.791 · neurodegeneration · 2026-04-02

## Mechanistic Overview Senescent Microglia Resolution via Maresins-Senolytics Combination starts from the claim that mo

Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathoge

Score: 0.780 · neurodegeneration · 2026-04-26

G2019S basal RAB10 phosphorylation elevation may be secondary; true pathogenic driver is amplified stress-response signa

CX3CR1-TREM2 Integration for Synapse Pruning Normalization

Score: 0.776 · neurodegeneration · 2026-04-16

## Mechanistic Overview CX3CR1-TREM2 Integration for Synapse Pruning Normalization starts from the claim that modulating

H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasi

Score: 0.770 · neurodegeneration · 2026-04-22

## Mechanistic Overview H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasis starts from th

Selective LXRβ agonists restore ABCA1/ABCG1 expression and APOE lipidation in AP

Score: 0.763 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The molecular basis for selective liver X receptor beta (LXRβ/NR1H2) agonism in A

TDP-43 Proteinopathy as a Cross-Disease Pathological Substrate

Score: 0.760 · neurodegeneration · 2026-04-28

TDP-43 misfolding and aggregation occurs as primary pathology in ALS/FTD (~95% and ~50% respectively) and as secondary p

Peripheral Monocyte/Macrophage Infiltration Mimicking Microglial Loss

Score: 0.743 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The proposed mechanism centers on liver disease-induced breakdown of blood-brain

APOE4-Selective Lipid Nanoemulsion Therapy

Score: 0.742 · neurodegeneration · 2026-04-02

## Mechanistic Overview APOE4-Selective Lipid Nanoemulsion Therapy starts from the claim that modulating APOE within the

Tau missorting transitions into an autonomous tau-seeding state after transient

Score: 0.740 · neurodegeneration · 2026-04-25

Transient Aβ exposure induces dendritic tau missorting that then converts into a locally self-propagating tau oligomer/s

Adenosine-Astrocyte Metabolic Reset

Score: 0.730 · neurodegeneration · 2026-04-02

## Mechanistic Overview Adenosine-Astrocyte Metabolic Reset starts from the claim that modulating ADORA2A within the dis

TFAM overexpression creates mitochondrial donor-recipient gradients for directed

Score: 0.725 · neurodegeneration · 2026-04-02

## Mechanistic Overview TFAM overexpression creates mitochondrial donor-recipient gradients for directed organelle traff

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen